Western Europe Eastern Europe Middle East South America Australia Asia Central America North America Africa
Our organization is widely acknowledged in this domain as the leading supplier of Diiodohydroxyquinoline. It is a halogenated oxyquinoline, a luminally active agent with efficacy for E. histolytica, dientamoeba fragilis, and blastocystis hominis. This drug is used to treat patients with asymptomatic shedding of cysts or as adjunctive therapy for patients being treated with other agents for invasive disease. Diiodohydroxyquinoline is available in oral form, but is poorly absorbed and should be given with meals. It is used as an intestinal antiseptic, especially as an antiamebic agent.